DDX39B (also known as BAT1) was proposed to be an anti-inflammatory factor (Allcock et al., 2001) and we have shown that DDX39B is genetically associated with MS, an autoimmune disease (Galarza-Muñoz et al., 2017). This evidence concerns the gene DDX39B and myeloid sarcoma.